It has been suggested that altered intestinal permeability may be important in the pathophysiology of various gastrointestinal diseasel-5 and it seems possible that increased permeability to antigens may account for some of the extraintestinal manifestation seen in these disorders.f"( Moreover it has been suggested that this increased intestinal permeability is important in other disorders, such as rheumatoid arthritis,"1 and atopic eczema,12 13 which are usually not associated with gastrointestinal symptoms.
We have recently described the use of 51-chromium-labelled ethylenediaminetetraacetate (51Cr-EDTA) as a test substance for detecting alterations in intestinal permeability in man both in vitro14 and in vivo.''By analysing urine excretion following oral administration of 51Cr-EDTA, we have demonstrated a persistent increase in intestinal permeability in patients with treated coeliac disease. 15 Our results from patients with inflammatory bowel disease indicate that the test is of value in discriminating between small intestinal involvement by Crohn's disease and inflammatory
The aim of this study was to examine the effects of hyperosmolar solutions on intestinal permeability and to investigate the importance of small bowel transit time in affecting the apparent permeability to 51Cr-EDTA. The absorption of 51Cr-EDTA was also examined in various models of experimentally induced enteropathies.
Methods

ANIMALS
Seven to nine week old male Sprague-Dawley rats, 220-390 g, were fed on a commercial diet (Standard Rodent Diet LAD1, K K -GREEFF Chemicals Ltd, Croydon). Water was allowed ad libitum but the animals were fasted overnight before use.
PROCEDURE
Gastric intubation was carried out under light ether anaesthesia and 1 ml of water containing 2 ,Ci, approximately 10 nmol, 9tCr-EDTA (Amersham International Ltd) administered, followed by 1 ml of water unless otherwise stated. The animals were placed in individual metabolic cages and killed by cervical dislocation five hours later. The abdomen was opened and the bladder emptied by puncture. The urine obtained (<0.2 ml) was mixed with that excreted during the five hour test period. The caecum was tied off with double ligatures. The small intestine was removed gently and double ligatures placed at the oesophago-gastric junction, the pylorus and 20 cm distal to the pylorus. The stomach, proximal, and distal small bowel, caecum and colon were removed. The different parts of intestine, faeces and urine were placed in a 25 ml container and disinfectant (ChlorosR, Womersley Boome Chemicals Ltd, Essex, UK) added up to 25 ml. Each sample was placed centrally between two detectors, set at minimal separation, in a high resolution bulk sample counter'7 and counted for 100 sec. The minimum detectable activity was 0 01% of the administered dose. The residual carcases were counted in the same counter at minimal possible detector separation.
HISTOLOGICAL ASSESSMENT
A sample was taken from each animal 2 and 20 cm distal to the pylorus and fixed in 10% formalin, embedded in wax and stained with haematoxilin and eosin for histological assessment (4 am sections). All samples were coded and randomly assessed. Morphometric analysis was performed by computer-aided microscopy (Magiscan). ' 20 21 are at its maximum.
STATI STICS
Wilcoxon's rank sum test was used for statistical analyses.
Results
VALIDATION OF METHOD OF PERMEABILITY MEASUREMENTS
Twelve rats were given the test solution and urine collected hourly for eight and then for 16 hours. Faeces were collected over the same period. The mean hourly urine excretion was 10% of the total 24 hour urine activity for each time period up to five hours. Radioactivity appeared in the faeces seven to eight hours after administration. As the faecal activity is high and contamination of the urine inevitable at this time, a five hour collection was used. Urine passed during the five hour period contained, on average, 50% (range 39-63%) of the total 24 hour urine activity. No detectable faecal activity was found in subsequent experiments during the five hour test period.
Eight rats were given a 10-fold higher dose of 51Cr-EDTA and killed five hours later. Caecal contents were removed and homogenised by five strokes of pestle A and five strokes of pestle B in 5 ml of 0*15 m NaCl (four rats) or in 15% (w/v) trichloracetic acid (TCA) (four rats) in a 7 ml Dounce tissue grinder (Kontes Glass Co, Vineland, New Jersey, USA). A 1 ml aliquot was centrifuged at 100 000 g for 30 min in a 10 x 10 angle rotor in a Superspeed 65 ultracentrifue (MSE Ltd, Crawley, Sussex, UK). The supernatant, pellet and 1 ml of homogenate were counted. Most (97-98%) of the radioactivity was found in the supernatant with total recoveries of 98-101%. the distorted architecture estimations of mucosal heights in duodenal samples were not possible but crypt depths did not differ from that of control animals ( Table 2 ). Gastric emptying was prolonged and transit times were delayed throughout the small intestine though this was less than that seen after atropine. The increased urine excretion of StCr-EDTA (Table 1) was markedly increased in spite of increased radioactivity in the carcass.
Methotrexate
All rats passed loose stools. times larger than that of Ca-EDTA (101t).28
Furthermore, the amount of EDTA used in our experiments is only 30 nmol compared with concentrations of 250 mM required to consistently alter permeability in the experimental animal. A 10-fold increase in the amount of StCr-EDTA had no effect on the percent urine excretion and therefore intestinal permeability was presumably unaltered. 5 Cr-EDTA was increased in these animals which differs from the conclusions with the sugar tests; these show a significant reduction in the absorption of both the di-and monosaccharides.2' 45 The reason for these differences are unclear but would seem to imply that the absorption pathways of 51Cr-EDTA differed from that of the disaccharides. Alternatively methotrexate treatment could allow small bowel bacterial overgrowth which would result in rapid degradation of the sugars and thus in the amount available for absorption. The decreased absorption could therefore erroneously be ascribed to decreased gut permeability.
In summary our results show that 5'Cr-EDTA is stable in the alimentary tract and that it is a convenient marker for assessing gastrointestinal permeability in the rat. Permeability estimations are dependent on test dose composition and minor alterations of gastric emptying and intestinal transit do not significantly affect the results. Experimentally-induced enteropathies were associated with increased urine excretion of 51Cr-EDTA which may reflect increased gastrointestinal permeability. Further studies using 'Cr-EDTA in both the experimental animal and man seem indicated to clarify the importance of altered intestinal permeability in the pathogenesis of small bowel disease and the extraintestinal manifestations.
